Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C)
Maartje E. Visser(Amsterdam UMC Location University of Amsterdam), Houshang Monajemi(University Medical Center Utrecht), Eric Kalkhoven(Utrecht University), Nicole Hamers(University Medical Center Utrecht), Arianne van Koppen(Netherlands Metabolomics Centre), E. Kropman(Amsterdam UMC Location University of Amsterdam), Erik S.G. Stroes(Amsterdam University Medical Centers), Mariëtte E.G. Kranendonk(Princess Máxima Center)
Cited by 40
Related Papers
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
|European Heart Journal|2015|1.4k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k